Darwin Global Management, Ltd. Intellia Therapeutics, Inc. Transaction History

Darwin Global Management, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $35.3 Million - $72.1 Million	-605,587 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $14.8 Million - $20.3 Million	-146,437 Reduced 19.47%	605,587 $71.6 Million
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $147 Million - $196 Million	-1,107,902 Reduced 59.57%	752,024 $101 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $113 Million - $301 Million	1,859,926 New	1,859,926 $301 Million

322

88.6M

673K

865K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.13B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.